The Growing Crisis of Million-Dollar Health Claims
American employers and benefits administrators are confronting a startling new reality: million-dollar health insurance claims have surged by 46%, and the trend shows no signs of slowing down. According to the latest High-Cost Claims and Injectable Drug Trends report from Sun Life U.S., secondary (comorbid) conditions, extended inpatient hospitalizations, and high-cost injectable drugs are the primary culprits behind this dramatic rise. An analysis of more than 70,000 high-dollar claims submitted by self-funded employers provides a detailed and sobering picture of what is driving healthcare expenditure to unprecedented levels.
For HR leaders, benefits consultants, and corporate decision-makers, understanding the mechanics behind this spike is no longer optional. It is a strategic imperative. The financial and human cost of these claims is reshaping how organizations think about employee health benefits, stop-loss insurance, and long-term workforce sustainability.
The Top Three Drivers of High-Cost Claims
The Sun Life report identifies three dominant forces accelerating the growth of million-dollar health claims. Each presents its own set of challenges and, importantly, its own set of potential intervention points.
1. Comorbid and Secondary Conditions
Comorbidities — the presence of two or more chronic conditions in a single patient — have long been recognized as a major contributor to high-cost claims, but their impact has never been more pronounced. When a patient arrives at a diagnosis with one or more existing conditions, treatment becomes exponentially more complex. Care pathways are longer, medication regimens are more intricate, and the risk of complications rises significantly. Recovery timelines stretch, and hospital stays lengthen.
The Sun Life data reveals particularly strong connections between cancer, cardiovascular disease, chronic kidney disease, and orthopedic and musculoskeletal (MSK) conditions. These four categories do not exist in isolation. They share overlapping risk factors — most notably age, obesity, diabetes, and systemic inflammation — making them highly likely to appear together in the same patient. When they do, the resulting claims can easily breach the million-dollar threshold and climb far beyond it.
2. Long Inpatient Hospitalizations
Extended hospital stays remain one of the most consistent predictors of catastrophic claim costs. When patients require prolonged inpatient care — whether due to surgical complications, infectious disease management, or the treatment of complex multisystem conditions — the cumulative cost of room charges, specialist consultations, imaging, laboratory work, and nursing care compounds rapidly. For self-funded employers, a single employee or dependent requiring weeks or months of inpatient treatment can disrupt an entire benefits budget cycle.
Conditions such as premature birth, complicated surgeries, and congenital anomalies are frequent triggers for these extended stays. Premature births in particular have been a top driver of multimillion-dollar claims for several consecutive years, as neonatal intensive care unit (NICU) costs can escalate into the millions for the most vulnerable infants.
3. Injectable Drugs and Gene Therapies
Perhaps no category reflects the changing landscape of modern medicine more dramatically than injectable drugs and gene therapies. Biologic medications, monoclonal antibodies, and gene-based treatments are transforming outcomes for patients with previously untreatable or poorly managed conditions. However, they come at an extraordinary price. A single course of gene therapy can cost several million dollars, and many injectable biologics carry annual price tags that alone can push a claim past the million-dollar mark.
The increasing adoption of these therapies across conditions ranging from spinal muscular atrophy to hemophilia to certain cancers means that high-cost injectable drug claims are likely to keep growing as a share of total healthcare expenditure. Employers and their stop-loss carriers must factor these costs into long-range financial modeling.
Conditions Most Frequently Behind Claims Over $3 Million
While many diagnoses can trigger high-cost claims, a smaller group of conditions consistently appears at the very top of the multimillion-dollar category. The Sun Life analysis highlights three in particular:
- Orthopedic and musculoskeletal (MSK) conditions: This category has only recently reached the multimillion-dollar tier, signaling both an increase in severity and rapid developments in surgical and pharmacological treatments. The fact that MSK conditions are also among the most frequent diagnoses for short-term disability claims underscores their broad impact on workforce productivity.
- Cancer: A perennial driver of catastrophic claims, cancer continues to rank among the highest-cost diagnoses year after year. New immunotherapies, targeted treatments, and combination regimens are improving survival rates but also pushing treatment costs to new highs.
- Premature birth: The medical and financial complexity of premature births has made this condition a consistent fixture in top-tier claims data. Advances in neonatal care have improved outcomes significantly, but the cost of those outcomes remains staggering.
What This Means for Self-Funded Employers
For organizations that self-fund their health benefits — meaning they assume direct financial responsibility for employee claims rather than paying fixed premiums to a fully insured carrier — the implications of this data are immediate and significant. Stop-loss insurance, which protects self-funded employers from catastrophic individual or aggregate claims, becomes both more critical and more expensive as high-cost claims multiply.
Beyond cost management, the data creates a compelling case for investment in proactive health management strategies. Identifying employees at risk for high-cost conditions before claims materialize is far less expensive than managing the claims after the fact. Chronic disease management programs, behavioral health integration, weight management support, and early cancer screening initiatives all represent evidence-based levers that employers can pull to reduce the long-term trajectory of claim costs.
The Intersection of Chronic Disease and Workforce Strategy
The rise in million-dollar claims is ultimately inseparable from the broader trend of increasing chronic disease prevalence in the American workforce. Conditions such as obesity, diabetes, hypertension, and metabolic syndrome are not only costly in their own right — they are the foundation upon which more expensive comorbid conditions develop. Addressing chronic disease at the population level is therefore not just a health initiative; it is a financial strategy with measurable return on investment.
HR leaders are increasingly being asked to act not only as benefits administrators but as architects of workforce health. That means partnering with data-driven stop-loss carriers, engaging condition management vendors, leveraging point-solution programs for high-risk populations, and using claims analytics to anticipate cost trends before they materialize in the annual budget.
Looking Ahead: Preparing for Continued Growth in High-Cost Claims
The 46% spike in million-dollar health claims is not an anomaly. It reflects structural changes in both the disease burden of the American workforce and the cost trajectory of modern medicine. As new gene therapies receive FDA approval, as the population ages, and as comorbid conditions become more prevalent, the frequency and severity of high-cost claims will continue to rise.
Employers and benefits professionals who engage with this data proactively — who use it to design smarter benefits structures, negotiate better stop-loss terms, and invest in prevention — will be better positioned to manage costs while still delivering meaningful health support to their employees. The organizations that treat this spike as a temporary anomaly to be absorbed, rather than a structural trend to be addressed, risk significant financial exposure in the years ahead.
Understanding what is driving million-dollar health claims is the first step. Building a strategy to manage them is the work that follows.